Advances in Clinical Pharmacology and Therapeutics

About the Journal

Advances in Clinical Pharmacology and Therapeutics (ACPT, E-ISSN: 2982-1460) is an international, peer-reviewed, open access journal on clinical pharmacology and therapeutics published quarterly online by Global Open Share Publishing.

Open Access: This journal operates under an Open Access model, providing free access to all readers. The Article Processing Charges (APC) for all article types (research, review, case reports) is $0, and the content will be published under a CC BY 4.0. To encourage submissions and support the research community, APCT currently levies no APC (0 APC). For specific APC policies, please refer to the Open Access Policies. 

Rapid Publication: The manuscript processing cycle is approximately 12 weeks from submission to acceptance.

Recognition of Reviewers: Reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in ACPT, in appreciation of the work done.

Abstracted/indexed in

General Information

    1st Year Published: 2024

    Frequency: Semi-annually

    Issues Per Year: 2

    Country / Region: Malaysia

    Primary Language: English

    Publisher Information: Cultech Publishing Sdn. Bhd.

Important Notice: Change of Publisher

2025-10-31

Please be informed that, effective from 1 November 2025 (commencing with Volume 3, Issue 1), Advances in Clinical Pharmacology and Therapeutics (ACPT, E-ISSN: 2982-1460) will be published by Cultech Publishing Sdn. Bhd., Malaysia.

The previous publisher was Global Open Share Publishing Pty Ltd, Australia. All issues published prior to 31 October 2025 (All volumes and issues from 2024-2025) remain the copyright and publication responsibility of the former publisher.

This transfer is part of the journal's strategic development. There will be no change to the journal's aims, scope, editorial board, or peer-review process. 

We thank Global Open Share Publishing Pty Ltd for their past stewardship and look forward to continuing to serve the academic community under the new publication arrangement.